U.S. markets closed
  • S&P Futures

    4,694.50
    +9.50 (+0.20%)
     
  • Dow Futures

    35,747.00
    +34.00 (+0.10%)
     
  • Nasdaq Futures

    16,368.50
    +50.50 (+0.31%)
     
  • Russell 2000 Futures

    2,258.80
    +4.90 (+0.22%)
     
  • Crude Oil

    71.63
    -0.42 (-0.58%)
     
  • Gold

    1,787.50
    +2.80 (+0.16%)
     
  • Silver

    22.51
    -0.01 (-0.06%)
     
  • EUR/USD

    1.1285
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.4800
    +0.0460 (+3.21%)
     
  • Vix

    21.89
    -5.29 (-19.46%)
     
  • GBP/USD

    1.3247
    +0.0005 (+0.04%)
     
  • USD/JPY

    113.4370
    -0.1030 (-0.09%)
     
  • BTC-USD

    50,447.07
    -238.55 (-0.47%)
     
  • CMC Crypto 200

    1,303.93
    -17.35 (-1.31%)
     
  • FTSE 100

    7,339.90
    +107.62 (+1.49%)
     
  • Nikkei 225

    28,699.58
    +243.98 (+0.86%)
     

How Merck's Antiviral Covid Pill Could Add To Its Already Bullish 2021 Outlook

·2 min read
How Merck's Antiviral Covid Pill Could Add To Its Already Bullish 2021 Outlook

Merck stock popped Thursday after beating expectations with 2021 guidance that could become richer if its Covid pill gains authorization.